Skip to main content
. 2025 Feb 11;25:113. doi: 10.1186/s12888-025-06544-6

Table 2.

Results from linear mixed model analyses

Dependent variable Estimate SE CI (95%) t p
BDI-II a c
 Time –1.60 0.23 –2.04 to − 1.15 –7.1 < 0.001
 Time x treatment –0.12 0.32 –0.76 to 0.53 –0.4 0.720
HDRS a d
 Time –6.93 0.97 –8.86 to − 5.01 –7.2 < 0.001
 Time x treatment –1.50 1.39 –4.25 to 1.26 –1.1 0.283
GAF-S b d
 Time 9.61 1.37 6.89 to 12.32 7.0 < 0.001
 Time x treatment 0.82 1.96 –3.09 to 4.73 0.4 0.677
GAF-F b d
 Time 11.63 1.38 8.90 to 14.37 8.5 < 0.001
 Time x treatment 0.15 1.98 –3.79 to 4.09 0.1 0.938
WSAS b c
 Time –1.38 0.20 –1.78 to − 0.98 –6.9 < 0.001
 Time x treatment 0.38 0.29 –0.19 to 0.94 1.3 0.192
SF-12 (MCS) b d
 Time 8.56 1.95 4.71 to 12.41 4.4 < 0.001
 Time x treatment –0.48 2.78 –5.96 to 5.00 –0.2 0.863
SF-12 (PCS) b d
 Time –0.58 1.43 –3.43 to 2.27 –0.4 0.689
 Time x treatment 0.02 2.05 –4.04 to 4.09 0.0 0.991
GAD-7 b c
 Time –0.50 0.11 –0.72 to − 0.28 –4.5 < 0.001
 Time x treatment –0.11 0.16 –0.43 to 0.20 –0.7 0.481

a Primary outcome. b Secondary Outcome. c Time points 0, 2, 4 and 7 months. d Time points 0 and 7 months. HDRS = Hamilton Depression Rating Scale; BDI-II = Beck Depression Inventory II; GAF-S = Global Assessment of Functioning, Symptom Score; GAF-F = Global Assessment of Functioning, Functioning Score; WSAS = Work and Social Adjustment Scale; SF-12 (MCS) = Short Form Health Survey, Mental Health Component Scale; SF-12 (PCS) = Short Form Health Survey, Physical Component Scale; GAD-7 = Generalized Anxiety Disorder-7